Difference between revisions of "Classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages"
Jump to navigation
Jump to search
(create) |
(tweak) |
||
| Line 1: | Line 1: | ||
'''Classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages''' is an evolving classification published by the Histiocyte Society. | '''Classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages''' is an evolving classification published by the ''Histiocyte Society''. | ||
The version published in 2016 consists of five groups:<ref name=pmid26966089>{{Cite journal | last1 = Emile | first1 = JF. | last2 = Abla | first2 = O. | last3 = Fraitag | first3 = S. | last4 = Horne | first4 = A. | last5 = Haroche | first5 = J. | last6 = Donadieu | first6 = J. | last7 = Requena-Caballero | first7 = L. | last8 = Jordan | first8 = MB. | last9 = Abdel-Wahab | first9 = O. | title = Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. | journal = Blood | volume = 127 | issue = 22 | pages = 2672-81 | month = 06 | year = 2016 | doi = 10.1182/blood-2016-01-690636 | PMID = 26966089 }}</ref> | The version published in 2016 consists of five groups:<ref name=pmid26966089>{{Cite journal | last1 = Emile | first1 = JF. | last2 = Abla | first2 = O. | last3 = Fraitag | first3 = S. | last4 = Horne | first4 = A. | last5 = Haroche | first5 = J. | last6 = Donadieu | first6 = J. | last7 = Requena-Caballero | first7 = L. | last8 = Jordan | first8 = MB. | last9 = Abdel-Wahab | first9 = O. | title = Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. | journal = Blood | volume = 127 | issue = 22 | pages = 2672-81 | month = 06 | year = 2016 | doi = 10.1182/blood-2016-01-690636 | PMID = 26966089 }}</ref> | ||
Revision as of 18:50, 23 July 2019
Classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages is an evolving classification published by the Histiocyte Society.
The version published in 2016 consists of five groups:[1]
| Group | Diseases | Details |
|---|---|---|
| L group | Langerhans cell histiocytosis (LCH), indeterminate cell histiocytosis, Erdheim-Chester disease (ECD), mixed LCH/ECD | |
| C group | cutaneous non-LCH, cutaneous non-LCH with major systemic component | cutaneous non-LCH subdivided into: XG family JXG, non-XG family |
| R group | familial Rosai-Dorfman disease (RDD), sporadic RDD | sporadic RCC includes: classical RDD, extra-nodal RDD, RDD with neoplasia or autoimmune disease, unclassified RDD |
| M group | primary malignant histiocytoses, secondary malignant histiocytoses | secondary malignant histiocytosis follow another hematologic malignancy; subclassified as: histiocytic, interdigitating, Langerhans, indeterminate cell |
| H group | primary hemophagocytic lymphohistiocytosis (HLH), secondary hemophagocytic lymphohistiocytosis, HLH or unknown/uncertain origin | secondary HLH is non-Mendelian |
See also
References
- ↑ Emile, JF.; Abla, O.; Fraitag, S.; Horne, A.; Haroche, J.; Donadieu, J.; Requena-Caballero, L.; Jordan, MB. et al. (06 2016). "Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.". Blood 127 (22): 2672-81. doi:10.1182/blood-2016-01-690636. PMID 26966089.